Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05636579
PHASE1

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

Sponsor: Asociación para Evitar la Ceguera en México

View on ClinicalTrials.gov

Summary

The goal of this clinical study is to assess the safety of multiple intracameral injections of EO2002 with and without topical Ripasudil.

Official title: Phase 1, Multiple Dose, Open-Label Study to Assess the Safety and Tolerability of EO2002 Intracameral Injections With or Without Topical Ripasudil in the Treatment of Corneal Edema

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2022-11-08

Completion Date

2025-12-09

Last Updated

2025-12-08

Healthy Volunteers

No

Interventions

BIOLOGICAL

EO2002

Intracameral injection of magnetic human corneal endothelial cells (EO2002)

DRUG

Ripasudil

Daily use of Ripasudil drops

Locations (1)

Asociacion para Evitar la Ceguera en Mexico

Mexico City, Mexico City, Mexico